BioSpace News Archive

SYNAPS Dx announces the selection of FrontRunner Health Care, a leading reimbursement technology provider, to help improve transparency for patients and providers on the out-of-pocket costs for the DISCERN™ test.

Andera Life Sciences, the business line specialising in innovative therapeutics and medical technologies of the asset management company Andera Partners, has announced the finalisation of its fundraising for its BioDiscovery 6 fund at 456 million euros.

This week Xiaokui Zhang , Ph.D., Chief Scientific Officer of Aspen Neuroscience, Inc. will present at the 2022 Cell & Gene Meeting on the Mesa Conference in Carlsbad, Calif.

DiscGenics, Inc. today announced that Matthew F. Gornet, MD, Board Certified Spine Surgeon at The Orthopedic Center of St. Louis, will present two-year follow-up data from the Company’s first-in-human clinical study of its allogeneic discogenic progenitor cell therapy (IDCT) for lumbar disc degeneration at the North American Spine Society (NASS) 37th Annual Meeting.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced findings of a new study to be presented during the North American Spine Society (NASS) 37th Annual Meeting on Thursday, October 13, 2022.

Intermountain Forensics, experts in cold case DNA analysis, announced the addition of a dedicated satellite lab for forensic genetic genealogy with new partner Astrea Forensics.

Jaswinder Grover, MD, Board-certified orthopedic and spine surgeon with more than 25 years of experience in the medical field, has been appointed to the Medical Advisory Board of Harvard MedTech.

Melzi Surgical, a surgical device company dedicated to creating innovative technologies that improve patient outcomes while reducing hospital expenses, highlighted results demonstrating accelerated time in locating lost surgical sharps using the Melzi Sharps Finder.

Medtronic plc released its fiscal year 2022 Integrated Performance Report: Engineering impact.

Organicell Regenerative Medicine, Inc. announced that the Company has added independent board members to its board of directors.